Jian Xie - 27 May 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
27 May 2025
Net transactions value
-$38,468
Form type
4
Filing time
28 May 2025, 16:17:07 UTC
Previous filing
29 Apr 2025
Next filing
03 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Xie Jian President and COO C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE /s/ Paul Kim as Attorney-in-Fact 28 May 2025 0001819718

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Sale $14,197 -690 -0.18% $20.58 373,814 27 May 2025 Direct F1, F2
transaction FLGT Common Stock Sale $24,271 -1,183 -0.32% $20.52 372,631 27 May 2025 Direct F3, F4
holding FLGT Common Stock 220,816 27 May 2025 By Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.
F2 The shares were sold in multiple transactions at prices ranging from $20.41 to $20.79, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 The shares were sold from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.
F4 The shares were sold in multiple transactions at prices ranging from $20.445 to $20.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.